Archive - April 2018
GSK reports Q1 sales decline
Shire warms to Takeda’s latest offer, extending deadline
Otsuka finally gets FDA OK for kidney disease drug
Pfizer takes aim at UK’s health tech industry
Women with breast cancer risk opting out of tamoxifen therapy
GSK/Innoviva’s Trelegy Ellipta wins expanded nod for COPD
Shire, Takeda move closer to merger deal
Pfizer’s Mylotarg wins EU approval for AML